Stuttgart - Delayed Quote • EUR
Stayble Therapeutics AB (4K4.SG)
As of 8:02 AM GMT+2. Market Open.
Breakdown
12/31/2022
12/31/2021
12/31/2020
Total Assets
19,147.5990
43,639.0470
17,996.9350
Total Liabilities Net Minority Interest
3,865.8970
3,831.4220
2,448.1750
Total Equity Gross Minority Interest
15,281.7020
39,807.6250
15,548.7600
Total Capitalization
15,281.7020
39,807.6250
15,548.7600
Common Stock Equity
15,281.7020
39,807.6250
15,548.7600
Net Tangible Assets
9,632.2900
34,158.2130
9,899.3480
Working Capital
10,482.2900
35,007.2130
10,943.7910
Invested Capital
15,281.7020
39,807.6250
15,548.7600
Tangible Book Value
9,632.2900
34,158.2130
9,899.3480
Total Debt
--
--
850.0000
Share Issued
14,228.3810
14,228.3810
8,925.8760
Ordinary Shares Number
14,228.3810
14,228.3810
8,925.8760
12/31/2020 - 8/29/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6JU.F BioCardia, Inc.
0.3320
-2.35%
IVACC.ST Intervacc AB (publ)
3.9950
-1.60%
SYNACT.ST SynAct Pharma AB
7.00
+1.38%
IMMU.ST Mendus AB (publ)
0.4670
-4.69%
BCDAW BioCardia, Inc.
0.0200
-25.37%
MACK Merrimack Pharmaceuticals, Inc.
14.71
-0.14%
REVB Revelation Biosciences, Inc.
2.0900
+0.97%
VRAX Virax Biolabs Group Limited
0.6636
+0.85%
ALLR Allarity Therapeutics, Inc.
1.3700
-3.52%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8450
+3.07%